Medicare Enrolled

Dr. Alexander Kassar, MD

Critical Care Medicine · Pomona, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
255 E BONITA AVE, Pomona, CA 91767
9094500158
In practice since 2013 (12 years)
NPI: 1588008767 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kassar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kassar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kassar

Dr. Alexander Kassar is a critical care medicine specialist in Pomona, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Kassar performed 4,482 Medicare services across 2,013 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kassar received a total of $4,583 from 20 pharmaceutical and/or device companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kassar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 5% volume in CA $4,583 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,482
Medicare services
Top 5% in CA for critical care medicine
2,013
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~374 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
1,533 $64 $132
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
1,329 $96 $203
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
477 $175 $335
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
292 $101 $246
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
275 $106 $225
Spirometry test
A test that measures the amount of air you can exhale and how fast you can blow it out. The provider evaluates the results to check lung function.
60 $19 $44
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
60 $32 $82
Lung volume measurement test
A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs.
60 $13 $36
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
60 $46 $107
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
60 $49 $114
Breathing device use evaluation
An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling.
50 $15 $31
Hemoglobin measurement
A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen.
49 $5 $15
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
48 $27 $62
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
47 $137 $321
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
41 $56 $109
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
30 $139 $336
Emergent tracheostomy
An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope.
11 $115 $301
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,583
Total received (2018-2024)
Avg $764/year across 6 years
Top 22% in CA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
165
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,570 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$844
2023
$1,489
2022
$1,293
2021
$211
2019
$434
2018
$311

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$233
GlaxoSmithKline, LLC.
$200
AstraZeneca Pharmaceuticals LP
$97
Baxter Healthcare
$80
GENZYME CORPORATION
$48
Actelion Pharmaceuticals US, Inc.
$45
Insmed, Inc.
$37
Philips North America LLC
$32
Mylan Specialty L.P.
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Merck Sharp & Dohme LLC
$18
Top 3 companies account for 62.8% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$987
AstraZeneca Pharmaceuticals LP
$832
Regeneron Healthcare Solutions, Inc.
$715
Boehringer Ingelheim Pharmaceuticals, Inc.
$575
United Therapeutics Corporation
$342
Genentech USA, Inc.
$190
Amgen Inc.
$167
GENZYME CORPORATION
$136
Baxter Healthcare
$134
Mallinckrodt LLC
$122
Intuitive Surgical, Inc.
$90
Shionogi Inc
$66
Actelion Pharmaceuticals US, Inc.
$45
Insmed, Inc.
$37
Gilead Sciences, Inc.
$32
Philips North America LLC
$32
Mylan Specialty L.P.
$31
Merck Sharp & Dohme LLC
$18
E.R. Squibb & Sons, L.L.C.
$18
Electromed, Inc.
$16
Top 3 companies account for 55.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · AREXVY · Arikayce · BREZTRI · DUPIXENT · Da Vinci Surgical System · ELIQUIS · FASENRA · Fetroja · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · NUCALA · OFEV · ORENITRAM · SMARTVEST · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · UPTRAVI · WINREVAIR · Xolair · YUPELRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a critical care medicine specialist in Pomona?
Compare critical care medicines in the Pomona area by procedure volume, costs, and industry payment transparency.
Browse critical care medicines nearby

Geographic Context

Critical care medicines within 10 mi
72
Per 100K population
0.7
County median income
$87,760
Nearest hospital
POMONA VALLEY HOSPITAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kassar is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kassar experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Kassar performed 1,533 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kassar receive payments from pharmaceutical companies?
Yes. Dr. Kassar received a total of $4,583 from 20 companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kassar's costs compare to other critical care medicines in Pomona?
Dr. Kassar's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kassar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →